We are live on ! Find out more
BSX icon

Boston Scientific

888 hedge funds and large institutions have $54.6B invested in Boston Scientific in 2021 Q4 according to their latest regulatory filings, with 121 funds opening new positions, 290 increasing their positions, 322 reducing their positions, and 95 closing their positions.

New
Increased
Maintained
Reduced
Closed

27% more first-time investments, than exits

New positions opened: 121 | Existing positions closed: 95

1% more funds holding

Funds holding: 877888 (+11)

3% less capital invested

Capital invested by funds: $56.3B → $54.6B (-$1.66B)

10% less repeat investments, than reductions

Existing positions increased: 290 | Existing positions reduced: 322

1.09% less ownership

Funds ownership: 91.5%90.41% (-1.1%)

18% less funds holding in top 10

Funds holding in top 10: 119 (-2)

42% less call options, than puts

Call options by funds: $271M | Put options by funds: $467M

Holders
888
Holders Change
+11
Holders Change %
+1.25%
% of All Funds
13.67%
Holding in Top 10
9
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-18.18%
% of All Funds
0.14%
New
121
Increased
290
Reduced
322
Closed
95
Calls
$271M
Puts
$467M
Net Calls
-$196M
Net Calls Change
-$17.7M
Name Holding Trade Value Shares
Change
Change in
Stake
Mercer Global Advisors
426
Mercer Global Advisors
Colorado
$1.09M +$82.7K +1,967 +8%
Rockefeller Capital Management
427
Rockefeller Capital Management
New York
$1.09M -$894K -21,281 -45%
CS
428
Comerica Securities
Michigan
$1.09M +$31.1K +740 +3%
SIA
429
Schechter Investment Advisors
Michigan
$1.08M +$1.07M +25,526 New
FTDI
430
First Trust Direct Indexing
Massachusetts
$1.08M -$3.28K -78 -0.3%
CAN
431
Cetera Advisor Networks
California
$1.07M +$154K +3,659 +17%
IIM
432
Intact Investment Management
Quebec, Canada
$1.07M
Cambridge Investment Research Advisors
433
Cambridge Investment Research Advisors
Iowa
$1.06M +$38.6K +918 +4%
CAPTRUST Financial Advisors
434
CAPTRUST Financial Advisors
North Carolina
$1.05M -$6.34K -151 -0.6%
EF
435
Empirical Finance
Pennsylvania
$1.03M +$274K +6,527 +37%
BWM
436
BNC Wealth Management
Oregon
$1.03M +$46.7K +1,112 +5%
RHBC
437
R.H. Bluestein & Co
Michigan
$1.02M
IC
438
IEQ Capital
California
$1.01M -$33.2K -789 -3%
LNWWM
439
Laird Norton Wetherby Wealth Management
California
$1M -$41.4K -986 -4%
IRF
440
IBM Retirement Fund
New York
$1M -$693K -16,493 -41%
APA
441
American Portfolios Advisors
New York
$987K +$3.82K +91 +0.4%
Cetera Investment Advisers
442
Cetera Investment Advisers
Illinois
$986K +$96.9K +2,305 +11%
TWC
443
TD Waterhouse Canada
Ontario, Canada
$969K +$925K +22,012 New
AWM
444
Accurate Wealth Management
Florida
$948K +$4.62K +110 +0.7%
PRWA
445
Platte River Wealth Advisors
Colorado
$935K -$13.9K -330 -2%
SLF
446
Sun Life Financial
Ontario, Canada
$921K +$74.2K +1,766 +9%
GWM
447
Geneos Wealth Management
Colorado
$903K +$123K +2,928 +16%
PDN
448
Pensionfund DSM Netherlands
Netherlands
$892K
FI
449
Fosun International
China
$888K
V
450
Veritable
Delaware
$887K +$15.1K +359 +2%

BSX Hedge Fund Activity: Q4 2021 in Review

888 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific (BSX) for Q4 2021, worth a combined $54.6B — down 3% from $56.3B a quarter earlier.

Buyers outnumbered sellers: 121 funds opened new BSX positions and 95 closed out — a net gain of 26 holders — while 290 added to existing stakes and 322 trimmed.

The largest buyer was Viking Global Investors, adding an estimated $508M. The largest seller was Wellington Management Group, cutting an estimated $391M.

  • 888 institutional investors held Boston Scientific (BSX) as of Q4 2021, up from 877 in Q3 2021.
  • Funds reported $54.6B of Boston Scientific stock for Q4 2021, down 3% quarter-over-quarter.
  • 121 funds opened new Boston Scientific positions in Q4 2021 and 95 closed out, a net change of +26 holders.
  • The largest Boston Scientific buyer in Q4 2021 was Viking Global Investors, an estimated $508M added.
  • The largest Boston Scientific seller in Q4 2021 was Wellington Management Group, an estimated $391M sold.

Based on aggregated 13F filings for Q4 2021.